FIELD: medicine. SUBSTANCE: method involves administering Karinate at a dose of 1 tablet twice a day after taking meals with 12 h long pause between the doses during 6 months. Then, the treatment courses are repeated. EFFECT: enhanced effectiveness in treating dyspepsia phenomena; suppressing Helicobacter pylori, intestinal metaplasia and dysplasia. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PROPHYLAXIS OF STOMACH CANCER | 2001 |
|
RU2214260C2 |
METHOD FOR HELICOBACTER PYLORI ERADICATION OF GASTRODUODENAL ZONE | 2014 |
|
RU2545687C1 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
DIAGNOSTIC TECHNIQUE FOR DEGREE OF ACTIVITY OF ANTRAL HELICOBACTER-ASSOCIATED GASTRITIS IN PATIENTS WITH BRONCHIAL ASTHMA | 2009 |
|
RU2394499C1 |
METHOD OF TREATING GASTRITIS | 2013 |
|
RU2519766C1 |
HELICO-BACTERIOSIS SIMULATION METHOD | 2018 |
|
RU2690943C1 |
METHOD FOR TREATING HELICOBACTER-ASSOCIATED CHRONIC DUODENAL ULCER | 2003 |
|
RU2252777C2 |
METHOD FOR ERADICATION OF HELICOBACTER PYLORI BACTERIA IN EXPERIMENTAL HELICOBACTERIOSIS IN CONVENTIONAL WHITE MICE AND A MEANS FOR ITS IMPLEMENTATION | 2020 |
|
RU2746590C1 |
METHOD FOR TISSUE THERAPY OF CHRONIC GASTRIC DISEASES | 2003 |
|
RU2234328C1 |
METHOD OF ASSESSING THE PROBABILITY OF ATROPHIC GASTRITIS IN PATIENTS WITH CHRONIC CORONARY HEART DISEASE | 2022 |
|
RU2806066C2 |
Authors
Dates
2003-12-27—Published
2002-07-25—Filed